Efficacy and Safety Study of 5 mg and 10 mg Rosuvastatin
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to compare the efficacy of Rosuvastatin 5 mg once daily
with Rosuvastatin 10 mg once daily by assessment of the number of patients with
hypercholesterolemia reaching the LDL-C target goal of <100 mg/dL after 12 weeks of therapy.
Phase:
Phase 4
Details
Lead Sponsor:
D16 Pharma & Biotec Ltd.
Collaborators:
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Dhaka Medical College National Institute of Cardiovascular Diseases